Amylin Pharmaceuticals Inc said its resubmission for approval of a diabetes drug was classified by U.S. health regulators as a class 2 response, which typically suggests a review period of six months.…
Read More »GLP-1 Once-Weekly Analogue Taspoglutide Found Safe and Effective
Taspoglutide demonstrates superiority in HbA1c change versus placebo as add-on to metformin and pioglitazone….
Read More »Interruptions Associated with Medication Errors by Nurses
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report.
Read More »Tight Blood Sugar Control May Not Harm Diabetes Patients
Reanalysis of an ACCORD study refutes link between intensive therapy, higher death risk….
Read More »Urinary Protein Marks Renal Risk in Hypertension
Elevated urinary albumin may be a trouble sign for the kidneys and heart in hypertensive patients even without diabetes, researchers found….
Read More »A1c Below Diabetes Levels Predicts CVD
Researchers found that HbA1c values significantly predicted CVD or death, whereas FPG levels were not significant after adjustment for other risk factors. The additional usefulness of HbA1c may….
Read More »Moderate Drinking Linked to 44%-65% Lower Diabetes Risk
Adults who have a drink or two per day may have a lower diabetes risk than teetotalers and the link does not appear to be explained by …
Read More »Half of US Adults Have Diabetes, Hypertension, or Hypercholesterolemia
Nearly half of all adults in the US have one chronic condition associated with an increased risk of cardiovascular disease, according to data from the National Health and Nutrition Examination Survey (NHANES)….
Read More »Diabetic Macular Edema Improves with New Teatment
Patients with diabetic macular edema saw more improvement when intravitreal ranibizumab (Lucentis) was added to photocoagulation laser treatment than with laser alone, according to results of a National Eye Institute-sponsored study….
Read More »Aspirin Use in Newly Diagnosed Diabetes Patients Remains Controversial
Regular use of aspirin in patients who are 40 years or older with newly diagnosed Type 2 diabetes is cost-effective, according to a published study….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.